Current healthcare practices are reactive and use limited physiological and clinical information,
often collected months or years apart. Moreover, the discovery and profiling of blood …

As the global population becomes older, understanding the impact of aging on health and
disease becomes paramount. Recent advancements in multiomic technology have allowed …

The study of metabolomics and disease has enabled the discovery of new risk factors,
diagnostic markers, and drug targets. For neurological and psychiatric phenotypes, the …

Background: Our understanding of the pathophysiology underlying Alzheimer’s disease (AD)
has benefited from genomic analyses, including those that leverage polygenic risk score (…

INTRODUCTION A hallmark of Alzheimer's disease (AD) is the aggregation of proteins (amyloid
beta [A] and hyperphosphorylated tau [T]) in the brain, making cerebrospinal fluid (CSF) …

Objective Smoking increases cardiopulmonary and rheumatic disease risk, yet tobacco
cessation intervention is rare in rheumatology clinics. This study aimed to implement a …

Purpose We present a case report detailing a challenge in health information technology (HIT)
project implementations we term “stakeholder creep”: not thoroughly identifying which …

Background: Sphingomyelin (SM) levels have been associated with Alzheimer’s disease (AD),
but the association direction has been inconsistent and research on cerebrospinal fluid (…

Proteomic analysis of cerebrospinal fluid (CSF) holds great promise in understanding the
progression of neurodegenerative diseases, including Alzheimer's disease (AD). As one of the …

Objective Recognizing high blood pressure ( BP ) as the most prevalent cardiovascular risk
factor in patients with rheumatic diseases and all adults, experts recommend clinic protocols …